Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9194609 | Journal of Neuroimmunology | 2005 | 4 Pages |
Abstract
Neuronal growth factors may exert a neuroprotective effect in multiple sclerosis (MS). We found reduced levels of brain-derived neurotrophic factors (BDNF) in the serum and CSF of relapsing-remitting MS patients, which was reversed by therapy with glatiramer acetate. BDNF may play a protective role in MS, and immunomodulation therapy, such as with glatiramer acetate, may enhance the action this mechanism.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
David Azoulay, Veronika Vachapova, Boris Shihman, Ariel Miler, Arnon Karni,